Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
FDA unveils new pathway to speed custom gene editing therapies
Called the “plausible mechanism pathway,” the program is designed to offer a new way to market for personalized therapies, FDA officials said.
Angus Liu
Nov 12, 2025 5:00pm
FDA puts Tenaya heart disease gene therapy trial on hold
Nov 10, 2025 5:16am
uniQure's gene therapy for Huntington's hits FDA roadblock
Nov 3, 2025 10:03am
Astellas turns down option to license Taysha gene therapy—again
Oct 17, 2025 10:50am
Regeneron shares updated data on hearing loss gene therapy
Oct 12, 2025 10:18am
James Wilson's GEMMABio launches new gene therapy biotech
Oct 7, 2025 10:00am